213 related articles for article (PubMed ID: 15055992)
1. Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives.
Chand P; Babu YS; Bantia S; Rowland S; Dehghani A; Kotian PL; Hutchison TL; Ali S; Brouillette W; El-Kattan Y; Lin TH
J Med Chem; 2004 Apr; 47(8):1919-29. PubMed ID: 15055992
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
3. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Babu YS; Bantia S; Elliott AJ; Montgomery JA
J Med Chem; 2001 Dec; 44(25):4379-92. PubMed ID: 11728184
[TBL] [Abstract][Full Text] [Related]
4. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Babu YS; Chand P; Bantia S; Kotian P; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Elliott AJ; Parker CD; Ananth SL; Horn LL; Laver GW; Montgomery JA
J Med Chem; 2000 Sep; 43(19):3482-6. PubMed ID: 11000002
[No Abstract] [Full Text] [Related]
5. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
[TBL] [Abstract][Full Text] [Related]
7. Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.
Maring CJ; Stoll VS; Zhao C; Sun M; Krueger AC; Stewart KD; Madigan DL; Kati WM; Xu Y; Carrick RJ; Montgomery DA; Kempf-Grote A; Marsh KC; Molla A; Steffy KR; Sham HL; Laver WG; Gu YG; Kempf DJ; Kohlbrenner WE
J Med Chem; 2005 Jun; 48(12):3980-90. PubMed ID: 15943472
[TBL] [Abstract][Full Text] [Related]
8. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
Stoll V; Stewart KD; Maring CJ; Muchmore S; Giranda V; Gu YG; Wang G; Chen Y; Sun M; Zhao C; Kennedy AL; Madigan DL; Xu Y; Saldivar A; Kati W; Laver G; Sowin T; Sham HL; Greer J; Kempf D
Biochemistry; 2003 Jan; 42(3):718-27. PubMed ID: 12534284
[TBL] [Abstract][Full Text] [Related]
9. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
10. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun C; Zhang X; Huang H; Zhou P
Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W
Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo.
Chand P; Bantia S; Kotian PL; El-Kattan Y; Lin TH; Babu YS
Bioorg Med Chem; 2005 Jun; 13(12):4071-7. PubMed ID: 15911320
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.
Liu Y; Zhang L; Gong J; Fang H; Liu A; Du G; Xu W
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):506-13. PubMed ID: 21143042
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and anti-influenza viral activities of 1,3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors.
Kinger M; Park YD; Park JH; Hur MG; Jeong HJ; Park SJ; Lee WS; Kim SW; Yang SD
Arch Pharm Res; 2012 Mar; 35(4):633-8. PubMed ID: 22553055
[TBL] [Abstract][Full Text] [Related]
17. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
[TBL] [Abstract][Full Text] [Related]
18. Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.
Sakamoto J; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Esumi Y; Nakamura T; Hatano K; Terunuma D; Matsuoka K
Bioorg Med Chem; 2009 Aug; 17(15):5451-64. PubMed ID: 19592257
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.
Chand P; Kotian PL; Morris PE; Bantia S; Walsh DA; Babu YS
Bioorg Med Chem; 2005 Apr; 13(7):2665-78. PubMed ID: 15755666
[TBL] [Abstract][Full Text] [Related]
20. Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.
Karis ND; Loughlin WA; Jenkins ID; Healy PC
Bioorg Med Chem; 2009 Jul; 17(13):4724-33. PubMed ID: 19443226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
